What's time got to do with it? Inattention to duration in interpretation of survival graphs.

Published

Journal Article

Reports of randomized clinical trials often use survival curves to summarize clinical outcomes over time and graphically demonstrate evidence of treatment effectiveness. Survival curves can also be used in patient communications to display how health risks accumulate over time. In a randomized survey experiment, administered online, we tested whether people viewing survival curves appropriately adjust their risk perceptions to account for the duration shown. Internet users (N= 864) were recruited from a demographically balanced U.S. panel. Participants read about a hypothetical disease and then viewed one of four survival graphs that displayed mortality risks with and without treatment. Survival graphs showed either a visually large or visually small difference between treatments and were labeled to represent either 5-year or 15-year risk statistics. Participants then provided ratings of disease seriousness, as well as treatment effectiveness for each possible treatment. Variations in ratings corresponded more with visual dissimilarity than with changes in the statistical risk exhibited, with participants perceiving somewhat greater disease seriousness and significant differences in treatment effectiveness in large visual difference graphs. We conclude that when people interpret survival curves, they often fail to sufficiently account for the timeframe represented and perceive more risk and larger differences when identical risks are displayed over longer periods of time. We recommend that all presentations of survival graphics, whether to patients, physicians, or scientists, emphasize duration information (e.g., in the title) and remind readers that attending to graph axis labels is the only way to pierce these visual illusions.

Full Text

Duke Authors

Cited Authors

  • Zikmund-Fisher, BJ; Fagerlin, A; Ubel, PA

Published Date

  • June 2005

Published In

Volume / Issue

  • 25 / 3

Start / End Page

  • 589 - 595

PubMed ID

  • 16022692

Pubmed Central ID

  • 16022692

Electronic International Standard Serial Number (EISSN)

  • 1539-6924

International Standard Serial Number (ISSN)

  • 0272-4332

Digital Object Identifier (DOI)

  • 10.1111/j.1539-6924.2005.00626.x

Language

  • eng